Novel and Future Therapeutic Drugs for Advanced Mycosis Fungoides and Sézary Syndrome
Mycosis fungoides (MF) and Sézary syndrome (SS) are the most common subtypes of cutaneous T-cell lymphoma. The majority of MF cases present with only patches and plaques and the lesions are usually limited to the skin. On the other hand, in some cases, patients show skin tumors or erythroderma follo...
Main Authors: | Tomonori Oka, Tomomitsu Miyagaki |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-05-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fmed.2019.00116/full |
Similar Items
-
The incidences of other primary cancers in patients with mycosis fungoides and Sézary syndrome
by: Izabela Błażewicz, et al.
Published: (2021-05-01) -
The MicroRNA Expression Profile Differs Between Erythrodermic Mycosis Fungoides and Sézary Syndrome
by: Anne Hald Rittig, et al.
Published: (2019-09-01) -
A rare association of bullous pemphigoid with mycosis fungoides and Sézary syndrome
by: Andjela Egger, BS, et al.
Published: (2020-06-01) -
Mycosis fungoides and Sézary syndrome: clinical, histopathological and immunohistochemical review and update Micose fungóide e síndrome de Sézary: revisão e atualização clínica, histopatológica e imuno-histoquímica
by: Thamy Yamashita, et al.
Published: (2012-12-01) -
Current Opportunities for Treatment Optimization of Mycosis Fungoides and Sezary Syndrome
by: NG Chernova, et al.
Published: (2018-01-01)